[ad_1]
NeuroFlow, a behavioral well being firm, secured a $25 million development funding led by development fairness affect investor SEMCAP Well being, bringing its whole funding to $32 million.
The corporate raised $7.5 million in a Collection A funding spherical in 2019 and $20 million in Collection B financing in 2021.
WHAT THEY DO
NeuroFlow’s cloud-based platform permits healthcare suppliers to trace, assess and join with sufferers between conventional workplace visits. The corporate additionally gives AI-driven scientific determination help with suggestions for the subsequent steps for particular person sufferers.
The Pennsylvania-based firm will use the funds to increase its community and improve R&D investments to develop its platform. It’s going to additionally improve its workforce in all departments.
“We’re excited to usher in a powerful associate like SEMCAP to help our subsequent stage of development. This offers us the chance to fulfill the demand we’re experiencing and to spend money on a platform that helps ship a happier, more healthy high quality of life for these throughout the spectrum of psychological well being wants. With this financing, we’ll concentrate on strategic hiring, R&D for the platform and the launch of a Spanish-language app,” James Kanka, NeuroFlow’s vice chairman of promoting, advised MobiHealthNews in an e-mail.
MARKET SNAPSHOT
Final month, NeuroFlow introduced a collaboration with CirrusMD, a startup providing on-demand, text-based telehealth, the place CirrusMS would leverage NeuroFlow’s scientific determination help platform, affected person engagement instruments and intervention providers.
In February, NeuroFlow introduced a partnership with Aflac, giving the insurance coverage supplier’s staff entry to digital psychological well being assets by way of NeuroFlow’s instructional content material service.
Source link